The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

PRRS Vaccines-Global Market Insights and Sales Trends 2025

PRRS Vaccines-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1846667

No of Pages : 119

Ask Your Query
Synopsis
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The global PRRS Vaccines market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of PRRS Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling PRRS Vaccines market. Live Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Killed Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for PRRS Vaccines market, driven by demand from China, the second largest economy with some signs of stabilising, the PRRS Vaccines market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PRRS Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PRRS Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PRRS Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PRRS Vaccines covered in this report include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc.
The global PRRS Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Global PRRS Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PRRS Vaccines market, Segment by Type:
Live Vaccines
Killed Vaccines
Global PRRS Vaccines market, by Application
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of PRRS Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 PRRS Vaccines Market Overview
1.1 PRRS Vaccines Product Overview
1.2 PRRS Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global PRRS Vaccines Market Size by Type
1.3.1 Global PRRS Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global PRRS Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global PRRS Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PRRS Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe PRRS Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific PRRS Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America PRRS Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa PRRS Vaccines Sales Breakdown by Type (2018-2023)
2 Global PRRS Vaccines Market Competition by Company
2.1 Global Top Players by PRRS Vaccines Sales (2018-2023)
2.2 Global Top Players by PRRS Vaccines Revenue (2018-2023)
2.3 Global Top Players by PRRS Vaccines Price (2018-2023)
2.4 Global Top Manufacturers PRRS Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 PRRS Vaccines Market Competitive Situation and Trends
2.5.1 PRRS Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by PRRS Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into PRRS Vaccines Market
2.8 Key Manufacturers PRRS Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PRRS Vaccines Status and Outlook by Region
3.1 Global PRRS Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PRRS Vaccines Historic Market Size by Region
3.2.1 Global PRRS Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global PRRS Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global PRRS Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global PRRS Vaccines Forecasted Market Size by Region
3.3.1 Global PRRS Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global PRRS Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global PRRS Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PRRS Vaccines by Application
4.1 PRRS Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global PRRS Vaccines Market Size by Application
4.2.1 Global PRRS Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global PRRS Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global PRRS Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PRRS Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe PRRS Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific PRRS Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America PRRS Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa PRRS Vaccines Sales Breakdown by Application (2018-2023)
5 North America PRRS Vaccines by Country
5.1 North America PRRS Vaccines Historic Market Size by Country
5.1.1 North America PRRS Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PRRS Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America PRRS Vaccines Sales in Value by Country (2018-2023)
5.2 North America PRRS Vaccines Forecasted Market Size by Country
5.2.1 North America PRRS Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America PRRS Vaccines Sales in Value by Country (2024-2029)
6 Europe PRRS Vaccines by Country
6.1 Europe PRRS Vaccines Historic Market Size by Country
6.1.1 Europe PRRS Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PRRS Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe PRRS Vaccines Sales in Value by Country (2018-2023)
6.2 Europe PRRS Vaccines Forecasted Market Size by Country
6.2.1 Europe PRRS Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe PRRS Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific PRRS Vaccines by Region
7.1 Asia-Pacific PRRS Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific PRRS Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PRRS Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific PRRS Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific PRRS Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific PRRS Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PRRS Vaccines Sales in Value by Region (2024-2029)
8 Latin America PRRS Vaccines by Country
8.1 Latin America PRRS Vaccines Historic Market Size by Country
8.1.1 Latin America PRRS Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PRRS Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America PRRS Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America PRRS Vaccines Forecasted Market Size by Country
8.2.1 Latin America PRRS Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America PRRS Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa PRRS Vaccines by Country
9.1 Middle East and Africa PRRS Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa PRRS Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PRRS Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa PRRS Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa PRRS Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa PRRS Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PRRS Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAHIC
10.1.1 CAHIC Company Information
10.1.2 CAHIC Introduction and Business Overview
10.1.3 CAHIC PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CAHIC PRRS Vaccines Products Offered
10.1.5 CAHIC Recent Development
10.2 Merial
10.2.1 Merial Company Information
10.2.2 Merial Introduction and Business Overview
10.2.3 Merial PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merial PRRS Vaccines Products Offered
10.2.5 Merial Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MSD Animal Health PRRS Vaccines Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Chopper Biology
10.4.1 Chopper Biology Company Information
10.4.2 Chopper Biology Introduction and Business Overview
10.4.3 Chopper Biology PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chopper Biology PRRS Vaccines Products Offered
10.4.5 Chopper Biology Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ceva PRRS Vaccines Products Offered
10.5.5 Ceva Recent Development
10.6 ChengDu Tecbond
10.6.1 ChengDu Tecbond Company Information
10.6.2 ChengDu Tecbond Introduction and Business Overview
10.6.3 ChengDu Tecbond PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 ChengDu Tecbond PRRS Vaccines Products Offered
10.6.5 ChengDu Tecbond Recent Development
10.7 Veterinary
10.7.1 Veterinary Company Information
10.7.2 Veterinary Introduction and Business Overview
10.7.3 Veterinary PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Veterinary PRRS Vaccines Products Offered
10.7.5 Veterinary Recent Development
10.8 Ringpu Biology
10.8.1 Ringpu Biology Company Information
10.8.2 Ringpu Biology Introduction and Business Overview
10.8.3 Ringpu Biology PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ringpu Biology PRRS Vaccines Products Offered
10.8.5 Ringpu Biology Recent Development
10.9 Qilu Animal
10.9.1 Qilu Animal Company Information
10.9.2 Qilu Animal Introduction and Business Overview
10.9.3 Qilu Animal PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Qilu Animal PRRS Vaccines Products Offered
10.9.5 Qilu Animal Recent Development
10.10 DHN
10.10.1 DHN Company Information
10.10.2 DHN Introduction and Business Overview
10.10.3 DHN PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 DHN PRRS Vaccines Products Offered
10.10.5 DHN Recent Development
10.11 CAVAC
10.11.1 CAVAC Company Information
10.11.2 CAVAC Introduction and Business Overview
10.11.3 CAVAC PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 CAVAC PRRS Vaccines Products Offered
10.11.5 CAVAC Recent Development
10.12 Komipharm
10.12.1 Komipharm Company Information
10.12.2 Komipharm Introduction and Business Overview
10.12.3 Komipharm PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Komipharm PRRS Vaccines Products Offered
10.12.5 Komipharm Recent Development
10.13 Agrovet
10.13.1 Agrovet Company Information
10.13.2 Agrovet Introduction and Business Overview
10.13.3 Agrovet PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Agrovet PRRS Vaccines Products Offered
10.13.5 Agrovet Recent Development
10.14 Bioveta
10.14.1 Bioveta Company Information
10.14.2 Bioveta Introduction and Business Overview
10.14.3 Bioveta PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Bioveta PRRS Vaccines Products Offered
10.14.5 Bioveta Recent Development
10.15 Jinyu Bio-Technology
10.15.1 Jinyu Bio-Technology Company Information
10.15.2 Jinyu Bio-Technology Introduction and Business Overview
10.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jinyu Bio-Technology PRRS Vaccines Products Offered
10.15.5 Jinyu Bio-Technology Recent Development
10.16 Institutul Pasteur
10.16.1 Institutul Pasteur Company Information
10.16.2 Institutul Pasteur Introduction and Business Overview
10.16.3 Institutul Pasteur PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Institutul Pasteur PRRS Vaccines Products Offered
10.16.5 Institutul Pasteur Recent Development
10.17 MVP
10.17.1 MVP Company Information
10.17.2 MVP Introduction and Business Overview
10.17.3 MVP PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 MVP PRRS Vaccines Products Offered
10.17.5 MVP Recent Development
10.18 Tecon
10.18.1 Tecon Company Information
10.18.2 Tecon Introduction and Business Overview
10.18.3 Tecon PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Tecon PRRS Vaccines Products Offered
10.18.5 Tecon Recent Development
10.19 Zoetis
10.19.1 Zoetis Company Information
10.19.2 Zoetis Introduction and Business Overview
10.19.3 Zoetis PRRS Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Zoetis PRRS Vaccines Products Offered
10.19.5 Zoetis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PRRS Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PRRS Vaccines Industrial Chain Analysis
11.4 PRRS Vaccines Market Dynamics
11.4.1 PRRS Vaccines Industry Trends
11.4.2 PRRS Vaccines Market Drivers
11.4.3 PRRS Vaccines Market Challenges
11.4.4 PRRS Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PRRS Vaccines Distributors
12.3 PRRS Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock